Kainova Therapeutics rebrand reflects expanding capabilities powering next stage of corporate growth Kainova champions scientific agility, bold ambition, and unity of purposeMontreal, Canada, ...
Rheumatoid arthritis (RA) is the leading indication, accounting for approximately 36% of the total market value, or USD 35.7 ...
According to DataM Intelligence, the global Inflammatory Diseases Biologics Market was valued at USD 99.06 billion in 2024 and is projected ...
As poultry producers continue to shift away from antibiotic growth promoters (AGPs), the role of probiotics in maintaining ...
Supports Genmab’s ambition to build an AI-enabled innovation model that advances the company’s vision of bringing transformative antibody medicines to patientsCOPENHAGEN, Denmark--(BUSINESS WIRE)--#AI ...
Discover how scorpion venom harvesting is becoming a high-value industry in Nigeria, transforming a feared toxin into a ...
Today, Lucent Health, one of the nation's largest independent third-party administrators, announced the appointment of Aadam ...
Incregen Therapeutics Advances First-in-Class GIP Ligand Antagonist INC-118 into IND-Enabling Development to Address Long-Term Obesity Management INC-118 directly antagonizes the circulating Glucose ...
In an RL-based control system, the turbine (or wind farm) controller is realized as an agent that observes the state of the ...
Creating/joining a "garage band" offers young men (and women) enumerable personal benefits across all spheres of personal and ...
CBeyondTM Phase 2a 26-week extension data update and interim results expected Q1 2026. CBeyond Phase 2a Data Monitoring Committee (DMC) meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback